Cargando…

Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease

We treated a myelin oligodendrocyte glycoprotein (MOG) antibody disease patient who had been prescribed dimethyl fumarate because she was thought to have been suffering from multiple sclerosis (MS). Mild optic neuritis relapsed at one year and four months after the administration of dimethyl fumarat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warabi, Yoko, Takahashi, Toshiyuki, Isozaki, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886657/ https://www.ncbi.nlm.nih.gov/pubmed/31824807 http://dx.doi.org/10.7759/cureus.6040

Ejemplares similares

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
por: Perez-Giraldo, Gina, et al.
Publicado: (2023)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
por: Seok, Jin Myoung, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis
por: Ishikura, Teruyuki, et al.
Publicado: (2022)

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19
por: Woodhall, Mark, et al.
Publicado: (2020)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2023)

Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients
por: Zhong, Xiaonan, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
por: Zhang, Min, et al.
Publicado: (2020)

Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
por: Alshamrani, Foziah, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Unilateral Autoimmune Encephalitis: A Case Report on a Rare Manifestation of Myelin Oligodendrocyte Glycoprotein Antibody Disease
por: Maturu, Mohan V. Sumedha, et al.
Publicado: (2023)

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective
por: Wang, Yufei, et al.
Publicado: (2023)

Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
por: Hua, Yi, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting With Orbital Apex Syndrome
por: Sulaiman, Farhana Nabila, et al.
Publicado: (2023)

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Simone, Marta, et al.
Publicado: (2021)

Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy
por: Alkabie, Samir, et al.
Publicado: (2022)

Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum
por: Budhram, Adrian, et al.
Publicado: (2022)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
por: Xu, Jie, et al.
Publicado: (2021)

The Successful Treatment of Severe Trigeminal Neuralgia by a Single Mandibular Nerve Block and Subsequent Natalizumab Administration in a Patient with Multiple Sclerosis
por: Norioka, Ryohei, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
por: Mao, Leilei, et al.
Publicado: (2019)

Aseptic Meningitis as an Initial Manifestation of Anti-myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
por: Suzuki, Takehiro, et al.
Publicado: (2019)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Ali, Liaquat, et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein-Associated Disorders Post-ChAdOx1 Vaccination
por: Maramattom, Boby Varkey
Publicado: (2022)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
por: Takai, Yoshiki, et al.
Publicado: (2023)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Clinical and Radiological Features of Adult Onset Bilateral Medial Frontal Cerebral Cortical Encephalitis With Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Fujimori, Juichi, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease With False-Positive Results in SARS-CoV-2 Antigen Tests: A Case Report
por: Yamamoto, Naoki, et al.
Publicado: (2022)

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
por: Kim, Hyunjin, et al.
Publicado: (2020)

A Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Responsive to Intravenous Immunoglobulin (IVIG) Therapy in a Pediatric Patient
por: Kadam, Rochita, et al.
Publicado: (2023)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

Case Report: Four Cases of Cortical/Brainstem Encephalitis Positive for Myelin Oligodendrocyte Glycoprotein Immunoglobulin G
por: Wang, Wan, et al.
Publicado: (2022)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
por: Kang, Hao, et al.
Publicado: (2020)

Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease
por: Ladakis, Dimitrios C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2njdnmv0bjte2abtmn03h3l1ia